Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Silicon Biosystems Forms U.S. Subsidiary To Commercialize Deparray™ Technology

Abstract:
Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc.,to be headquartered in San Diego, California.

Silicon Biosystems Forms U.S. Subsidiary To Commercialize Deparray™ Technology

Bologna, Italy | Posted on December 13th, 2010

The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics markets for the company's DEPArray™ technology platform.

"The formation of our own commercial operation in the U.S. represents a significant step forward for our business," stated Giuseppe Giorgini, CEO of Silicon Biosystems, S.p.A. "Our DEPArray™ platform will allow clinicians and researchers working to advance personalized medicine in areas such as clinical oncology to identify new biomarkers and improve patient treatment based on genetic information they have previously not had access to. We are excited to begin commercial discussions with thought leaders in the U.S."

The company's DEPArray™ technology exploits microelectronics and the principles of dielectrophoresis to isolate and manipulate cells in a suspension matrix. The approach, patented by Silicon Biosystems, offers the unique possibility of controlling individual cells and micro-particles inside a disposable cartridge. The DepArray™ platform makes it possible to find, sort, select and separate individual cells for further analysis or culturing.

####

About Silicon Biosystems
Silicon Biosystems, S.p.A. is based in Bologna Italy and has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems is one of the most innovative start-ups in the field of "lab-on-a-chip," based on active substrates, as testified by a number of awards and recognitions. The company is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.

For more information, please click here

Contacts:
Nicole Lee
(619) 814-2370, x11
(951) 533-8315(mobile)

Copyright © Silicon Biosystems

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Openings/New facilities/Groundbreaking/Expansion

New Agricultural Research Center Debuts at UCF October 12th, 2016

Nexeon Establishes Base in Asia October 11th, 2016

GLOBALFOUNDRIES to Expand Presence in China with 300mm Fab in Chongqing: Company plans new manufacturing facility and additional design capabilities to serve customers in China May 31st, 2016

Albertan Science Lab Opens in India May 7th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project